Transfer of adverse reaction data to pharmacovigilance systems
Елена Матвеева2021-06-01T23:31:54+03:00According to the WHO rules, monitoring and transfer of information about AD drugs to the VigiBase database can only be carried out by National Pharmacovigilance Centers organized in different countries. Pharmacovigilance documents, pharmacovigilance standard operating procedures (SOPs), master file - all this should be formed according to the same rules. Each country wishing to become [...]